What could you uncover with data from over 3,500 participants with prostate cancer? 🤔ðŸ’
With close to 3,000 prevalent cases of prostate cancer within our participant population, CanPath remains committed to continuing to support participants and researchers in uncovering new breakthroughs in prostate cancer prevention, detection and treatment.
By collecting biological, genetic and health data from our participants, we can keep track of new and existing cases of prostate cancer to provide researchers with access to invaluable health information to support the next generation of cancer research.
🔗 Get inspired by the latest prostate cancer publications using CanPath data: http://bit.ly/46VMeqJ
Last Updated on September 26, 2025